Related Experiment Videos
Differential expression levels of Par-4 in melanoma
T Lucas1, B Pratscher, S Krishnan
1Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.
Abstract:
The pro-apoptotic prostate apoptosis response-4 gene product Par-4 sensitizes prostate cells to the induction of programmed cell death. In this study we examined Par-4 expression in human melanoma cell lines and melanoma metastases. The heterogeneous expression detected prompted us to investigate the biological relevance of Par-4 in a human melanoma xenotransplantation model. Overexpression of Par-4 by transfection decreased tumour development in xenotransplanted A375-C6 melanoma cells in SCID mice and correlated to an increase in tumour cell apoptosis. These data suggest that high expression of the pro-apoptotic protein Par-4 could qualify as a prognostic marker in human melanoma.
Insights
The pro-apoptotic gene Par-4 (prostate apoptosis response-4) sensitizes cells to programmed cell death. High Par-4 expression in melanoma may serve as a prognostic marker, as it reduced tumor development and increased apoptosis in a mouse model.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate apoptosis response-4 (Par-4) is a pro-apoptotic gene product.
- Par-4 sensitizes prostate cells to programmed cell death.
- Melanoma is a significant form of skin cancer.
Purpose of the Study:
- To investigate the expression of Par-4 in human melanoma cell lines and metastases.
- To determine the biological relevance of Par-4 in melanoma development.
- To assess the potential of Par-4 as a prognostic marker for human melanoma.
Main Methods:
- Analysis of Par-4 expression in melanoma cell lines and patient metastases.
- Overexpression of Par-4 in A375-C6 melanoma cells via transfection.
- Xenotransplantation of modified melanoma cells into SCID mice.
- Assessment of tumor development and tumor cell apoptosis.
Main Results:
- Heterogeneous expression of Par-4 was detected in human melanoma.
- Overexpression of Par-4 significantly decreased tumor development in a xenotransplantation model.
- Increased tumor cell apoptosis was observed in Par-4 overexpressing xenografts.
- Par-4 expression levels correlated with tumor cell apoptosis.
Conclusions:
- High expression of the pro-apoptotic protein Par-4 may serve as a prognostic marker in human melanoma.
- Par-4 plays a role in regulating melanoma cell apoptosis and tumor growth.
- Targeting Par-4 could be a potential therapeutic strategy for melanoma.